Search research articles
Contact Us
Filters
Showing results (341-350 of 375) with videos related to
Page
of 38
Sort By:
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 15, 2022
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force
Don Husereau, Michael Drummond, Federico Augustovski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 15, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 27, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
BMC Health Services Research
|
January 27, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
Health Policy OPEN
|
June 29, 2023
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
June 19, 2016
Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model
Andrew H Briggs, Timothy Baker, Nancy A Risebrough, et al.
Plos Medicine
|
May 15, 2014
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review
Jenni Hislop, Temitope E Adewuyi, Luke D Vale, et al.
Health Technology Assessment (Winchester, England)
|
June 6, 2026
PERsonalised Medicine for Intensification of Treatment (PERMIT) in type 2 diabetes mellitus: a target trial emulation from routine data
David G Lugo-Palacios, Patrick Bidulka, Paul Charlton, et al.
Health Technology Assessment (Winchester, England)
|
May 9, 2014
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review
Jonathan A Cook, Jennifer Hislop, Temitope E Adewuyi, et al.
BMJ (Clinical Research Ed.)
|
May 8, 2024
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data
Patrick Bidulka, David G Lugo-Palacios, Orlagh Carroll, et al.
Page
of 38
Search research articles
Search
Showing results (341-350 of 375) with videos related to
Sort By:
Page
of 38
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 15, 2022
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) 2022 Explanation and Elaboration: A Report of the ISPOR CHEERS II Good Practices Task Force
Don Husereau, Michael Drummond, Federico Augustovski, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
January 15, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) Statement: Updated Reporting Guidance for Health Economic Evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
The European Journal of Health Economics : HEPAC : Health Economics in Prevention and Care
|
January 27, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
BMC Health Services Research
|
January 27, 2022
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
Health Policy OPEN
|
June 29, 2023
Consolidated Health Economic Evaluation Reporting Standards 2022 (CHEERS 2022) statement: Updated reporting guidance for health economic evaluations
Don Husereau, Michael Drummond, Federico Augustovski, et al.
Medical Decision Making : an International Journal of the Society for Medical Decision Making
|
June 19, 2016
Development of the Galaxy Chronic Obstructive Pulmonary Disease (COPD) Model Using Data from ECLIPSE: Internal Validation of a Linked-Equations Cohort Model
Andrew H Briggs, Timothy Baker, Nancy A Risebrough, et al.
Plos Medicine
|
May 15, 2014
Methods for specifying the target difference in a randomised controlled trial: the Difference ELicitation in TriAls (DELTA) systematic review
Jenni Hislop, Temitope E Adewuyi, Luke D Vale, et al.
Health Technology Assessment (Winchester, England)
|
June 6, 2026
PERsonalised Medicine for Intensification of Treatment (PERMIT) in type 2 diabetes mellitus: a target trial emulation from routine data
David G Lugo-Palacios, Patrick Bidulka, Paul Charlton, et al.
Health Technology Assessment (Winchester, England)
|
May 9, 2014
Assessing methods to specify the target difference for a randomised controlled trial: DELTA (Difference ELicitation in TriAls) review
Jonathan A Cook, Jennifer Hislop, Temitope E Adewuyi, et al.
BMJ (Clinical Research Ed.)
|
May 8, 2024
Comparative effectiveness of second line oral antidiabetic treatments among people with type 2 diabetes mellitus: emulation of a target trial using routinely collected health data
Patrick Bidulka, David G Lugo-Palacios, Orlagh Carroll, et al.
Page
of 38